Member Info for liquid1

8 weeks up next week

The Company's first assay, already in development, is an instrument-agnostic molecular assay (the Genedrive® 96 SARS-COV-2 test) that can be performed on a variety of high throughput molecular testing platforms already installed in many laboratories around the world. The test will determine if a patient has an active SARS-COV-2 infection. The Company anticipates that a clinically validated high throughput test format could be available in approximately eight weeks.



The Genedrive®96 SARS-COV-2 test is designed as a one-step, ready-to-go freeze dried assay. Based on discussions with sizable third party suppliers the Company expects it could have the ability to ramp quickly to high production volumes of over 10,000 tests per hour, and thus this could be both a material revenue generator for the Company and significant contributor to addressing the global pandemic. Freeze dried assays require no refrigeration and are stable in transport, which is a significant logistical advantage for rapid shipment and global distribution.

Just to catch up with AVCT!

11 May 2020

Cobra Resources plc

("Cobra" or the "Company")

Block Listing Applications

Applications have been made to The UK Listing Authority and The London Stock Exchange for three block listings of ordinary shares of 1p each to trade on The London Stock Exchange and to be admitted to The Official List. The aggregate of 98,515,957 ordinary shares will rank equally with the existing issued shares of the Company.

Ahh ok for hearing loss not covid-19!

Hopefully that will be here within 14 days

company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® mt-RNR1-ID kit has received CE-IVD Certification and will be launched into Europe and other markets following full evaluation by the UK National Health Service. The Company has assays on market for the detection of HCV, certain military biological targets, and has tests in development for tuberculosis (mTB). The company recently announced the development of the high throughput SARS-CoV-2 assay, based on Genedrive PCR chemistry.

The Genedrive® mt-RNR1-ID kit has received CE-IVD Certification and will be launched into Europe and other markets following full evaluation by the UK National Health Service.

Seriously ****ed off with management for doing a placing prior to assay results! Stinks of an I consistent result.

Remind me of these guys who did a placing just to see a negative result:

RMP
MTFB
IMM
etc! FFS why state assay results in 2-4 weeks, and then give us effing sweet FA!

£127k Buy

Nice

On Monday you can say “Next week for CE mark”

Back to 300p next week

Looks like placing is now factored in!

"We look forward to updating the market in the coming weeks on the results of the Stage 2 exploration programme at Wudinna"

Are the results not good???

654 samples is a lot!!!!!

654 samples being sent to ALS laboratories in Adelaide. The programme saw the collection of 104 new samples at the Barns prospect - Southern Extension; Baggy Green - South; Baggy Green South East; and the Clarke prospect, as well as 550 re-assays of previous samples.

NT to buy!
Roll on news!

07 Apr 2020 10:00 am
RNS
Factsheet Cobra Resources PLC (COBR) Successful Completion of Stage 2 and ADI Funding
---------------------------------------------
17 Mar 2020 8:33 am
RNS
Factsheet Cobra Resources PLC (COBR) Wudinna Exploration Programme Update - Stage 2
-----------------------------------------------
18 Feb 2020 10:18 am
RNS
Factsheet Cobra Resources PLC (COBR) Wudinna Exploration Programme Update
--------------------------------------------
23 Dec 2019 12:09 pm
RNS
Factsheet Cobra Resources PLC (COBR) Update on RTO and Re-Listing of Company
------------------------------------------
21 Oct 2019 8:07 am
RNS
Factsheet Cobra Resources PLC (COBR) Wudinna Project - Drilling Equity Agreement

Maybe the interview was postponed to next week because he was told by ALS lab that the 654 sample results were coming to him today?????

So RNS could be tomorrow or Monday?

All 654 samples are being subjected to 48-element geochemical analysis to facilitate the new chemical fingerprint technique announce on the 27th of March, which established that elevated Bismuth, Tellurium, Tungsten, Copper and Silver in soils were strong pathfinders to basement gold mineralisation.

Once these results have been received and analysed, a further update will be provided to the market.

The Wudinna Project lies on the Eyre Peninsular of South Australia and comprises six tenements that total 1928km2 in the Central Gawler Craton Gold Province of South Australia.
The project includes a cluster of deposits and earlier stage prospects including the Barns Deposit (“Barns”), the Baggy Green Deposit (“Baggy Green”) and the White Tank Deposit (“White Tank”). These deposits have Mineral Resources totalling 4.43 million tonnes at 1.5g/t gold for 211,000 ounces using a 0.5g/t gold cut-off grade, comprised of 0.41 million tonnes at 1.40g/t gold for 18,000 ounces of Indicated Resources and 4.02 million tonnes at 1.5g/t gold for 193,000 ounces of Inferred Resources.

https://www.cobraresources.co.uk/cobra-projects/the-wudinna-project

Yesterday volume 29m

Free float 44m.

MM’s must be running short of shares

The shares burst into life this afternoon with a four-fold increase to hit a staggering 81p intraday-high, before settling at around 50p each.